[Close]
This page was created by volunteers like you!
Help us make it even better. To learn more about contributing to MEpedia, click here.
Join the movement
Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
Congratulations!
MEpedia has got over 30 million views as of August 2022!

Rivaroxaban

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from Xarelto)

Rivaroxaban is a novel oral anticoagulant (NOAC) drug and a Factor Xa inhibitor, which is sold under the brand name Xarelto.[1]

Theory[edit | edit source]

Evidence[edit | edit source]

Clinicians[edit | edit source]

Risks and safety[edit | edit source]

Costs and availability[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. ↑ "Rivaroxaban Uses, Side Effects & Warnings". Drugs.com. Retrieved August 2, 2022.
Retrieved from "https://me-pedia.org/w/index.php?title=Rivaroxaban&oldid=202648"